Vincent Ling

Vincent Ling serves as Chief Business Officer at Morphocell Technologies. Morphocell Technologies operates in the research sector with approximately 33.0 employees. The company is headquartered in Cambridge, Massachusetts.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,468 c suite-level executives.

Outlook Google Cloud Hosting Wix Varnish Mobile Friendly

biotechnology research cell therapy liver disease engineered tissues acute liver failure chronic liver failure ipsc-derived cells allogeneic therapy transplantation alternatives regenerative medicine hepatic encephalopathy immunosuppressive therapy biotechnology preclinical trials metabolic diseases tissue engineering transient implants clinical translation regenerative solutions stem cell therapy biomaterials therapeutic development cell manufacturing surgical implantation safety data manufacturing processes cutting-edge therapies therapeutic innovation patient-centered care research partnerships biologics quality by design clinical scale product pipeline medical breakthroughs research associate scientific expertise healthcare technologies stem cell differentiation sustainable therapies clinical trials disease management biotech innovation crispr technology process development venture capital research funding regulatory affairs biotech leadership health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Vincent Ling in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Morphocell Technologies.

Vincent Ling's Position in the MessageCEO Database

• •Vincent Ling is 1 of 1 verified executive contact we track at Morphocell Technologies.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,577 verified executive contacts in Massachusetts are in the database.
• •36 verified contacts work at research companies in the 33.0 employee range (same size as Morphocell Technologies).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated August 2026.

How do I reach Vincent Ling directly?

Vincent Ling's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Business Officer at Morphocell Technologies. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Vincent Ling work for?

Vincent Ling is Chief Business Officer at Morphocell Technologies, a company in the research sector with 33.0 employees. The company is based in Cambridge, Massachusetts.

Can I pitch or sell to Vincent Ling?

As Chief Business Officer at Morphocell Technologies, Vincent Ling is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Vincent Ling directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Vincent Ling in?

Vincent Ling works in the research industry as Chief Business Officer at Morphocell Technologies. MessageCEO provides verified contact information for executives across all major industries.

Is Vincent Ling's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Vincent Ling's profile is kept up-to-date with the latest available information.

Last updated: August 3, 2026